Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol +/- Simvastatin in Portal Hypertension
NCT02465645Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jun 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of simvastatin in Portal Hypertension (PH) and esophageal varices, sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Total number of patients who will be Responders at 3 months. Started Jun 2015; status: completed.
02
Drugs
simvastatin
03
Conditions
Portal Hypertension (PH)esophageal varices
Beyond the preview
Go deeper on NCT02465645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465645.